SG11202109123XA - Pharmaceutical dosage form for application to mucous membranes and methods for producing same - Google Patents

Pharmaceutical dosage form for application to mucous membranes and methods for producing same

Info

Publication number
SG11202109123XA
SG11202109123XA SG11202109123XA SG11202109123XA SG11202109123XA SG 11202109123X A SG11202109123X A SG 11202109123XA SG 11202109123X A SG11202109123X A SG 11202109123XA SG 11202109123X A SG11202109123X A SG 11202109123XA SG 11202109123X A SG11202109123X A SG 11202109123XA
Authority
SG
Singapore
Prior art keywords
methods
application
dosage form
pharmaceutical dosage
mucous membranes
Prior art date
Application number
SG11202109123XA
Inventor
Julius Krause
Original Assignee
Esocap Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esocap Ag filed Critical Esocap Ag
Publication of SG11202109123XA publication Critical patent/SG11202109123XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074—Filling capsules; Related operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A61J7/0061—Swallow helping devices, e.g. tongue shields
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/007—Injectors for solid bodies, e.g. suppositories
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0625—Mouth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1042—Alimentary tract
    • A61M2210/1067—Anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/14—Female reproductive, genital organs
    • A61M2210/1475—Vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
SG11202109123XA 2019-03-14 2020-03-13 Pharmaceutical dosage form for application to mucous membranes and methods for producing same SG11202109123XA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19162908 2019-03-14
EP19192961 2019-08-21
PCT/EP2020/056934 WO2020183005A1 (en) 2019-03-14 2020-03-13 Pharmaceutical dosage form for application to mucous membranes and methods for producing same

Publications (1)

Publication Number Publication Date
SG11202109123XA true SG11202109123XA (en) 2021-09-29

Family

ID=69941338

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109123XA SG11202109123XA (en) 2019-03-14 2020-03-13 Pharmaceutical dosage form for application to mucous membranes and methods for producing same

Country Status (21)

Country Link
US (1) US20220151939A1 (en)
EP (1) EP3937902B1 (en)
JP (1) JP7396557B2 (en)
KR (1) KR20210142660A (en)
CN (1) CN113727698A (en)
AU (1) AU2020234029A1 (en)
BR (1) BR112021017069A2 (en)
CA (1) CA3131148A1 (en)
DK (1) DK3937902T3 (en)
ES (1) ES2970329T3 (en)
FI (1) FI3937902T3 (en)
HU (1) HUE064867T2 (en)
IL (1) IL285899A (en)
MX (1) MX2021010972A (en)
PL (1) PL3937902T3 (en)
SG (1) SG11202109123XA (en)
SI (1) SI3937902T1 (en)
TW (1) TWI829888B (en)
UY (1) UY38610A (en)
WO (1) WO2020183005A1 (en)
ZA (1) ZA202105976B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3198970A1 (en) * 2020-11-09 2022-05-12 Lts Lohmann Therapie-System Ag Oral thin film
JP2024519920A (en) 2021-05-21 2024-05-21 エゾカップ アーゲー Capsule device having a gap formed by overlapping two half capsule shells
CN117693377A (en) 2021-05-21 2024-03-12 伊斯凯普公司 Capsule device with an aperture formed by a wall portion of one of the two half-capsule shells
WO2023237426A1 (en) 2022-06-07 2023-12-14 Esocap Ag Drug delivery system comprising a reflux inhibitor for the application to esophageal mucous membranes
WO2023237425A1 (en) 2022-06-07 2023-12-14 Esocap Ag Drug delivery system comprising an anti-inflammatory agent or a salt thereof for the application to esophageal mucous membranes
WO2023237431A1 (en) 2022-06-07 2023-12-14 Esocap Ag Drug delivery system comprising an agent effective in the treatment or prevention of an esophageal disease for the application to esophageal mucous membranes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1151823A (en) 1982-09-02 1983-08-16 Leonard Mackie Hard shell gelatin capsule dipping apparatus and method
WO1991017745A1 (en) * 1990-05-23 1991-11-28 Southwest Research Institute Filament system for delivering a medicament and method
AU650113B2 (en) * 1991-04-05 1994-06-09 Eli Lilly And Company Sustained release capsule and formulations
AUPQ254199A0 (en) * 1999-08-31 1999-09-23 University Of Western Australia, The Methods and devices for obtaining samples from hollow viscera
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
WO2005039499A2 (en) * 2003-10-24 2005-05-06 Adhesives Research, Inc. Rapidly disintegrating film
HUE043365T2 (en) * 2006-01-18 2019-08-28 Intec Pharma Ltd Delivery device for oral intake of an agent
EP2432437A4 (en) * 2009-05-21 2012-12-19 Bionex Pharmaceuticals Llc Dual and single layer dosage forms
US20120321706A1 (en) * 2009-10-19 2012-12-20 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
PT3653223T (en) * 2011-06-29 2021-12-06 Rani Therapeutics Llc Device for the oral delivery of therapeutic compounds
US20140335153A1 (en) * 2013-05-09 2014-11-13 Cure Pharmaceutical Corporation Thin film with high load of active ingredient
US20160235663A1 (en) * 2013-09-26 2016-08-18 Medimetrics Personalized Drug Delivery, B.V. Delivery capsule with threshold release
DE102014119576A1 (en) * 2014-12-23 2016-06-23 Ernst-Moritz-Arndt-Universität Greifswald Pharmaceutical form for administration to mucous membranes

Also Published As

Publication number Publication date
SI3937902T1 (en) 2024-03-29
UY38610A (en) 2020-08-31
AU2020234029A1 (en) 2021-09-16
WO2020183005A1 (en) 2020-09-17
TWI829888B (en) 2024-01-21
ZA202105976B (en) 2023-04-26
JP2022524109A (en) 2022-04-27
PL3937902T3 (en) 2024-04-15
FI3937902T3 (en) 2024-01-30
ES2970329T3 (en) 2024-05-28
KR20210142660A (en) 2021-11-25
MX2021010972A (en) 2021-10-13
HUE064867T2 (en) 2024-04-28
CA3131148A1 (en) 2020-09-17
EP3937902A1 (en) 2022-01-19
TW202103685A (en) 2021-02-01
IL285899A (en) 2021-10-31
BR112021017069A2 (en) 2021-11-09
US20220151939A1 (en) 2022-05-19
JP7396557B2 (en) 2023-12-12
DK3937902T3 (en) 2024-01-29
CN113727698A (en) 2021-11-30
EP3937902B1 (en) 2023-11-01

Similar Documents

Publication Publication Date Title
IL285899A (en) Pharmaceutical dosage form for application to mucous membranes and methods for producing same
EP3705118A4 (en) Oral solid dosage form composition having improved disintegration and preparation method therefor
HK1244691A1 (en) Pharmaceutical dosage form for application to mucous membranes
EP3714887A4 (en) Pharmaceutical composition for topical administration and preparation method therefor
MX2017015137A (en) Once daily oral pharmaceutical composition of isotretinoin.
HK1247140A1 (en) Method and system for effective breath-synchronized delivery of medicament to the lungs
HK1217303A1 (en) Pharmaceutical composition for treatment of leukemia and preparation method thereof
EP3485886A4 (en) Oral pharmaceutical composition of tecovirimat and preparation method therefor
EP3311809A4 (en) Use of pharmaceutical composition in preparation of drug for promoting chondrocyte generation
EP3468540A4 (en) Pharmaceutical compositions and methods for treatment of pain
EP3375443A4 (en) Pharmaceutical composition for treating respiratory diseases
HK1245094A1 (en) Pharmaceutical composition for treatment of depression and preparation method thereof
IL239958A (en) Chewable composition for oral administration and process for preparation thereof
EP3972691A4 (en) Methods and pharmaceutical compositions to treat drug overdose
EP3485876A4 (en) Oral pharmaceutical composition and method for producing particulate formulation comprising composition
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
PL3369429T3 (en) Pharmaceutical composition intended to be administered to nasal mucosa
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
EP3290037A4 (en) Pharmaceutical composition for oral administration
ZA202110948B (en) Pharmaceutical dosage forms and methods for their production
HK1245097A1 (en) Pharmaceutical composition for treatment of menopausal syndrome and preparation method thereof
MX2014005153A (en) Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain.
EP3381467A4 (en) Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration
IN2013MU03428A (en)
MX2020000213A (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof.